Collagen-II Bovine

Bovine Collagen-II
Shipped with Ice Packs
In Stock

Description

Biochemical Properties and Sources

Collagen-II bovine consists of three identical α1(II) chains forming a triple-helical structure. Key characteristics include:

  • Source: Extracted from bovine knee joints or articular cartilage via controlled pepsin digestion and salt precipitation .

  • Structure: Exhibits a D-periodic axial arrangement with 67 nm repeats, critical for fibril integrity .

  • Homology: Highly conserved across species (e.g., bovine, porcine, human), enabling cross-species therapeutic applications .

Osteoarthritis (OA) Management

  • Mechanism: Undenatured collagen-II (40 mg/day) may stimulate regulatory T cells to reduce joint inflammation .

  • Efficacy:

    • In rats, oral undenatured collagen-II (1.33–2 mg/kg) reduced knee swelling and improved gait within 14 days .

    • Human trials show improved self-reported pain and stiffness, though structural cartilage preservation remains unproven .

Cartilage Engineering

Collagen-II scaffolds enhance hyaline cartilage repair by promoting chondrocyte differentiation and extracellular matrix (ECM) synthesis:

Scaffold CompositionKey FindingsReference
Bovine collagen-II + CS + HAIncreased aggrecan, collagen-II, and COMP gene expression in chondrocytes
Bovine collagen-II + BM + ThAchieved hyaline-like repair with reduced inflammation in rabbit defects

Comparative Efficacy in Arthritis Models

ConditionCollagen-II FormOutcomeStudy Type
Rheumatoid Arthritis (RA)Solubilized (0.5 mg/day)No improvement vs. placebo; worsened symptomsHuman trial
OsteoarthritisUndenatured (40 mg/day)Reduced pain and stiffnessMeta-analysis

Research Advancements

  • Injectable Biomaterials: Collagen-II-based hydrogels combined with TGF-β1 and IGF-I enhanced glycosaminoglycan (GAG) deposition and COL2A1 expression in vivo .

  • Immune Compatibility: Crosslinked collagen-II scaffolds showed minimal immunogenicity, supporting long-term integration .

Product Specs

Introduction

Collagen, a key structural protein, is widely used in various industries due to its strength and abundance. However, traditional animal-sourced collagen poses risks such as inflammation, immune reactions, and potential contamination. Recombinant collagens offer a safer alternative, closely mimicking native collagen and reducing these risks.

Description

This product is a purified natural protein extracted from bovine knee joints using specialized chromatographic techniques.

Physical Appearance

It appears as a white, freeze-dried powder that has been filtered.

Formulation

This product is freeze-dried without any additional ingredients.

Solubility

To create a working solution (around 1-5mg/ml), add 50 mM acetic acid to the freeze-dried pellet and allow it to dissolve completely.

Stability

The freeze-dried product remains stable for 3 weeks at room temperature but should ideally be stored in a dry environment below -18°C. After reconstitution, store at 4°C for 2-7 days. For extended storage, freeze below -18°C, adding a carrier protein (0.1% HSA or BSA) is recommended. Avoid repeated freezing and thawing.

Purity

Greater than 95% pure.

Source

Bovine knee joint.

Q&A

What is Type II Collagen and where is it primarily found in bovine tissues?

Type II collagen is a fibrillar collagen characterized by its super-helical structure composed of three identical α1(II) chains. It is the predominant molecular form of collagen in cartilage tissue, making up a significant portion of the extracellular matrix. In bovine species, type II collagen is primarily located in articular cartilage, but is also found in the vitreous humor of the eye, the inner ear, the nose, and intervertebral discs of the spine. The primary function of bovine type II collagen is to provide tensile strength and give cartilage the ability to resist shearing forces in load-bearing joints . Type II collagen's unique molecular structure contributes to the biomechanical properties essential for joint function throughout the animal's lifespan.

How does bovine Type II collagen differ structurally and functionally from other collagen types?

Type II collagen differs from other collagen types primarily in its molecular composition and tissue distribution. While Type I collagen (the most abundant collagen type) forms thick fibrils found in bone, tendons, and skin, Type II collagen forms thinner fibrils specific to cartilaginous tissues. Structurally, bovine Type II collagen consists of three identical α1(II) chains, whereas Type I collagen consists of two α1(I) chains and one α2(I) chain. This structural difference results in distinct biomechanical properties suited to the function of cartilage versus other connective tissues . Functionally, Type II collagen provides the framework for proteoglycan aggregation in cartilage tissue, creating a hydrated gel-like structure that resists compression forces. This specialized function directly relates to its role in articular cartilage, where it must withstand both shearing and compressive forces .

What are the primary sources and extraction methods for bovine Type II collagen in research settings?

In research settings, bovine Type II collagen is primarily sourced from articular cartilage, particularly from fetal or young bovine joints where the collagen content is highest. Extraction typically involves a multi-step process beginning with mechanical disruption of cartilage tissue, followed by removal of proteoglycans and other non-collagenous proteins using salt or guanidine extractions. The collagen is then solubilized using acids (pepsin digestion in acetic acid is common), salts, enzymes, or auxiliary methods . For immunological studies, special care must be taken to preserve the native triple-helical structure by using mild extraction conditions and low temperatures. For applications requiring purified peptides, the extracted collagen undergoes further processing through controlled enzymatic or chemical hydrolysis to produce specific collagen fragments . The extraction method significantly impacts the structural integrity, solubility, and biological activity of the resulting collagen preparation.

What mechanisms explain the immunomodulatory effects of undenatured bovine Type II collagen in experimental arthritis models?

Undenatured bovine Type II collagen exhibits immunomodulatory effects through an oral tolerance mechanism. When administered orally, intact epitopes on the undenatured collagen are recognized by the gut-associated lymphoid tissue, particularly in Peyer's patches. This recognition induces the formation of regulatory T cells (Tregs) that can enter systemic circulation and produce anti-inflammatory compounds such as IL-10. These Tregs recognize the same collagen epitopes in arthritic joints, where they inhibit inflammatory responses and tissue damage . This mechanism is highly dependent on preserving the native triple-helical structure during collagen extraction and processing, as denaturation disrupts the key epitopes required for immune recognition. Studies have demonstrated that this mechanism is specific to native collagen, as hydrolyzed collagen does not induce the same immunomodulatory effect. The dosage for eliciting this response is notably lower (typically ~40 mg/day) than that of hydrolyzed collagen (typically ~10 g/day), reflecting the different biological mechanisms at work .

How do collagen crosslinks influence the structural integrity and biomechanical properties of bovine Type II collagen matrices?

Collagen crosslinks, particularly enzymatic crosslinks such as the mature trivalent pyridinoline (PYR) and the immature divalent dihydroxylysinonorleucine (DHLNL), play crucial roles in determining the structural integrity and mechanical properties of bovine Type II collagen matrices. These crosslinks form between the telopeptide regions and the helical portions of adjacent collagen molecules, creating a three-dimensional network that significantly enhances tensile strength, elasticity, and resistance to enzymatic degradation . The ratio of mature to immature crosslinks correlates with tissue maturation and mechanical stability. In bovine articular cartilage, this crosslinking process is regulated by lysyl oxidase enzymes and is influenced by factors such as tissue age, loading conditions, and disease states. Advanced research has shown that alterations in crosslink profiles can serve as early indicators of pathological changes in cartilage, preceding visible tissue degradation. Quantification of these crosslinks using diamond hydride chromatography with LC-MS allows researchers to assess the structural integrity of collagen networks in both normal and diseased cartilage with high sensitivity and specificity .

What is the molecular feedback mechanism by which collagen hydrolysate stimulates Type II collagen biosynthesis in bovine chondrocytes?

Research has revealed a dose-dependent stimulatory effect of collagen hydrolysate (CH) on Type II collagen biosynthesis in bovine chondrocytes, suggesting a sophisticated feedback mechanism for regulating collagen turnover in cartilage tissue. When bovine chondrocytes are cultured with degraded collagen, they respond by increasing the production and secretion of Type II collagen in a manner that is not observed with native collagens or non-collagenous protein hydrolysates . The molecular mechanism appears to involve specific bioactive peptides within the collagen hydrolysate that act as signaling molecules. These peptides may bind to cell surface receptors on chondrocytes, triggering intracellular signaling cascades that upregulate collagen gene expression and protein synthesis. The specificity of this response suggests that peptide sequences unique to collagen are recognized by chondrocytes as indicators of matrix turnover. This feedback mechanism may represent an evolutionary adaptation to maintain cartilage homeostasis by accelerating matrix synthesis when degradation products are detected, potentially offering therapeutic opportunities for cartilage regeneration strategies .

What analytical techniques provide quantitative differentiation between Type II collagen and other collagen subtypes in bovine tissue samples?

Accurate quantification and differentiation of Type II collagen from other collagen subtypes in bovine tissue samples requires sophisticated analytical approaches. Traditional methods like the hydroxyproline assay, while useful for total collagen content, cannot discriminate between collagen subtypes. For subtype-specific quantification, researchers now employ several advanced techniques:

How can researchers optimize extraction protocols to maintain the native triple-helical structure of bovine Type II collagen for immunological studies?

Maintaining the native triple-helical structure of bovine Type II collagen is critical for immunological studies, particularly those investigating oral tolerance mechanisms or autoimmune responses. Optimized extraction protocols should incorporate several key considerations:

  • Temperature Control: All extraction procedures should be performed at 4°C or lower to prevent thermal denaturation of the triple-helical structure. Rapid processing reduces exposure to denaturation conditions .

  • Mild Extraction Conditions: Using neutral salt solutions (e.g., 0.5M NaCl, 0.05M Tris-HCl, pH 7.4) for initial extraction helps maintain native conformations. Pepsin digestion should be carefully controlled and limited to removing only telopeptides while preserving the triple-helical region .

  • Protease Inhibitors: Including a cocktail of protease inhibitors (e.g., EDTA, N-ethylmaleimide, phenylmethylsulfonyl fluoride) throughout the extraction process prevents enzymatic degradation by endogenous proteases.

  • Sequential Extraction: Employing a multi-step extraction process that first removes proteoglycans and other non-collagenous proteins before collagen solubilization improves purity while reducing harsh treatments.

  • Purification Considerations: Using selective precipitation methods (with NaCl or ethanol) rather than heat denaturation for purification helps preserve the native structure.

  • Verification of Triple-Helical Integrity: Circular dichroism spectroscopy and differential scanning calorimetry should be employed to confirm the preservation of the triple-helical structure before using the preparation in immunological studies .
    These optimized protocols are essential for studies investigating the immunomodulatory properties of bovine Type II collagen, as denaturation eliminates the specific epitopes required for immune recognition and tolerance induction.

What is the comparative efficiency and specificity of different hydrolysis methods for generating bioactive bovine Type II collagen peptides?

The generation of bioactive bovine Type II collagen peptides through various hydrolysis methods shows significant differences in efficiency, specificity, and the resulting bioactive properties. A comparative analysis reveals:

Hydrolysis MethodEfficiencyPeptide Size RangeBioactivity ProfileLimitations
Enzymatic (Pepsin)Moderate2-20 kDaPreserves some triple-helical regions; maintains immunogenic epitopesLimited solubility; incomplete digestion
Enzymatic (Collagenase)High1-5 kDaProduces tissue-specific peptides; maintains some structural motifsBatch variability; enzyme cost
Enzymatic (Multi-enzyme)Very High0.5-3 kDaDiverse peptide profile; enhanced bioavailabilityComplex optimization; potential allergenicity
Acid HydrolysisVery High<1 kDaComplete breakdown; simple amino acids; low immunogenicityDestroys most bioactive epitopes; harsh conditions
Alkaline HydrolysisHigh<2 kDaRacemization of amino acids; altered bioactivityChemical modification of amino acids
Thermal HydrolysisModerateVariablePartial denaturation; maintains some structural elementsLow specificity; variable results
Research indicates that controlled enzymatic hydrolysis, particularly using specific collagenases, generates peptides with optimal chondroprotective and anti-inflammatory properties. These peptides appear to stimulate type II collagen synthesis in chondrocytes through specific receptor-mediated mechanisms . The bioactivity of these peptides is strongly influenced by their size distribution and the preservation of specific amino acid sequences derived from the original collagen structure. Multi-enzymatic approaches that mimic physiological digestion processes often yield peptide mixtures with superior bioavailability and cellular effects compared to single-enzyme or chemical hydrolysis methods .

How can bovine Type II collagen be effectively used in collagen-induced arthritis (CIA) models while controlling for experimental variables?

Bovine Type II collagen is frequently used to establish collagen-induced arthritis (CIA) models, which serve as important tools for studying autoimmune inflammatory arthritis. To ensure reproducible and reliable results, researchers must carefully control several experimental variables:

  • Collagen Preparation: Use immunization-grade bovine Type II collagen that has been purified from fetal bovine articular cartilage and maintained in a soluble, native triple-helical conformation (typically 2 mg/mL). The structural integrity should be verified by circular dichroism spectroscopy to ensure consistency between experiments .

  • Emulsion Preparation: Create a stable emulsion by combining equal volumes of collagen solution with complete Freund's adjuvant (for primary immunization) or incomplete Freund's adjuvant (for booster immunization). Ensure consistent emulsion quality by using standardized protocols for mixing (e.g., homogenization time and speed) .

  • Animal Selection: Choose genetically susceptible strains (e.g., DBA/1 mice for murine CIA models). Control for age (typically 8-12 weeks), sex (females often show more consistent responses), and housing conditions (temperature, humidity, light cycles) .

  • Immunization Protocol: Standardize the dose (typically 50-100 μg per mouse), route of administration (intradermal at the base of the tail is most common), and timing of primary and booster immunizations (typically 21 days apart).

  • Assessment Methods: Use consistent, objective methods for evaluating arthritis severity, including clinical scoring systems, measurement of paw swelling, histological analysis, and functional assessments .

  • Environmental Factors: Control for environmental factors that can influence disease development, including microbiome composition, diet, stress levels, and exposure to pathogens.
    By meticulously controlling these variables, researchers can establish reliable CIA models for investigating pathogenic mechanisms and potential therapeutic interventions for autoimmune arthritis .

What are the optimal cell culture conditions for studying the effects of bovine Type II collagen fragments on chondrocyte metabolism?

Establishing optimal cell culture conditions is critical for studying how bovine Type II collagen fragments influence chondrocyte metabolism. Based on research findings, the following parameters should be optimized:

  • Chondrocyte Isolation and Culture: Isolate primary bovine chondrocytes using sequential enzymatic digestion (pronase followed by collagenase) of articular cartilage from metacarpophalangeal joints of adult cattle. Culture cells in DMEM supplemented with 10% fetal bovine serum, ascorbic acid (50 μg/mL), and antibiotics at 37°C with 5% CO₂ .

  • Collagen Fragment Preparation: Prepare collagen hydrolysate by controlled enzymatic digestion of purified bovine Type II collagen. Characterize the resulting peptide mixture by size exclusion chromatography and mass spectrometry to ensure consistent size distribution (typically ranging from 1-10 kDa) .

  • Experimental Design: Culture chondrocytes for 5-7 days to reach stability before introducing collagen fragments. Test a range of concentrations (typically 0.1-10 mg/mL) to establish dose-response relationships. Include appropriate controls (native collagens, non-collagenous protein hydrolysates) .

  • Three-Dimensional Culture Systems: For more physiologically relevant conditions, establish three-dimensional culture systems using alginate beads or collagen scaffolds, which better maintain the chondrocyte phenotype compared to monolayer cultures .

  • Analysis of Collagen Synthesis: Quantify Type II collagen synthesis using multiple complementary methods, including ELISA for collagen protein, qRT-PCR for COL2A1 gene expression, and radiolabeling with ¹⁴C-proline followed by SDS-PAGE to visualize newly synthesized collagen chains .

  • Assessment of Chondrocyte Phenotype: Monitor expression of chondrocyte-specific markers (aggrecan, SOX9) and dedifferentiation markers (COL1A1) to ensure maintenance of the chondrocyte phenotype throughout the experiment .
    These optimized conditions enable reliable assessment of how bovine Type II collagen fragments influence chondrocyte metabolism, providing insights into potential mechanisms for cartilage repair and regeneration .

What analytical workflows best characterize the crosslink profile of bovine Type II collagen for structure-function correlation studies?

Characterizing the crosslink profile of bovine Type II collagen requires sophisticated analytical workflows to establish meaningful structure-function correlations. Based on current methodologies, an optimized analytical workflow includes:

  • Sample Preparation: Lyophilize cartilage tissue followed by pulverization in liquid nitrogen. Perform reduction of samples with sodium borohydride to stabilize crosslinks. Hydrolyze samples in 6N HCl at 110°C for 24 hours under nitrogen atmosphere to release crosslinks .

  • Crosslink Enrichment: Use cellulose chromatography or solid-phase extraction (SPE) with cation exchange materials to enrich and fractionate crosslinks from the hydrolysate.

  • Primary Analysis - Diamond Hydride Chromatography: Employ diamond hydride chromatography coupled with liquid chromatography-mass spectrometry (LC-MS) for separation and detection of crosslinks. This method provides excellent separation of both reducible and non-reducible crosslinks with high sensitivity .

  • Identification and Quantification: Use multiple reaction monitoring (MRM) in tandem mass spectrometry for specific detection of key crosslinks including pyridinoline (PYR), deoxypyridinoline (DPyr), dihydroxylysinonorleucine (DHLNL), and hydroxylysinonorleucine (HLNL). Quantify using isotopically labeled internal standards when available .

  • Mechanical Testing Correlation: Perform mechanical testing on adjacent tissue samples to determine tensile strength, compression resistance, and viscoelastic properties. Statistical methods such as multiple regression analysis can then correlate specific crosslink types and ratios with mechanical parameters.

  • Age and Disease-Related Analysis: Compare crosslink profiles across different age groups and disease states to identify patterns associated with normal maturation versus pathological changes.
    This comprehensive analytical workflow enables researchers to establish detailed structure-function relationships between collagen crosslinking patterns and the biomechanical properties of bovine articular cartilage, providing insights into both normal development and disease progression .

What new methodological approaches could improve the specificity of detecting post-translational modifications in bovine Type II collagen?

Post-translational modifications (PTMs) in bovine Type II collagen significantly influence its structural integrity and biological functions. Emerging methodological approaches that could improve detection specificity include:

  • Top-down Proteomics: This approach analyzes intact collagen molecules or large fragments rather than digested peptides, preserving information about co-occurring modifications and their spatial relationships. Advanced high-resolution mass spectrometry techniques like Fourier-transform ion cyclotron resonance (FT-ICR) provide the resolution necessary to distinguish subtle mass differences between similar modifications .

  • Targeted Glycoproteomics: Novel glycopeptide enrichment strategies combined with hydrophilic interaction liquid chromatography (HILIC) and electron-transfer dissociation (ETD) mass spectrometry can improve detection of site-specific glycosylation patterns in collagen, which affect fibril assembly and interactions with other matrix components.

  • Crosslink-Specific Derivatization: Chemical labeling strategies that target specific crosslink structures with fluorescent or mass-shifting tags can enhance detection sensitivity and specificity, particularly for labile or low-abundance crosslinks that are challenging to detect with conventional methods .

  • Imaging Mass Spectrometry: Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry can map the spatial distribution of collagen modifications directly in tissue sections, providing insights into region-specific variations in collagen structure.

  • Combinatorial Isotopic Labeling: Metabolic labeling with stable isotopes during in vitro culture of bovine chondrocytes enables tracking of newly synthesized collagen and the dynamic formation of specific modifications under controlled conditions .
    These advanced methodological approaches will enable more comprehensive characterization of the complex post-translational landscape of bovine Type II collagen, advancing our understanding of how these modifications influence collagen function in normal and pathological states .

How might the integration of bovine Type II collagen research with emerging bioprinting technologies advance cartilage tissue engineering?

The integration of bovine Type II collagen research with bioprinting technologies represents a promising frontier for cartilage tissue engineering. Several strategic research directions show particular promise:

  • Bioink Formulation Optimization: Developing bioinks that incorporate native or minimally processed bovine Type II collagen with preserved bioactive epitopes could enhance chondrogenic differentiation of embedded stem cells. Research needs to focus on optimizing rheological properties for printability while maintaining collagen's biological activity .

  • Crosslinking Strategies: Investigating enzymatic crosslinking methods (using transglutaminases or lysyl oxidases) that mimic natural crosslinking processes could improve the mechanical stability of printed constructs while preserving the bioactive properties of the collagen. This approach may produce more physiologically relevant cartilage constructs than chemical crosslinking methods .

  • Gradient Structures: Developing printing protocols that create biomimetic gradients of collagen density, fibril orientation, and crosslinking patterns could better recapitulate the zone-specific architecture of native articular cartilage, potentially improving functional outcomes in engineered tissues .

  • Incorporation of Collagen-Derived Bioactive Peptides: Supplementing bioinks with specific bioactive peptides derived from bovine Type II collagen that stimulate chondrocyte proliferation and matrix synthesis could enhance the biological performance of printed constructs. Research should identify the most potent peptide sequences and optimal concentrations .

  • In Situ Bioprinting: Exploring minimally invasive in situ bioprinting approaches using bovine collagen-based bioinks could enable direct deposition of cartilage constructs into defect sites, potentially improving integration with surrounding tissue and reducing the need for invasive surgical procedures.
    These research directions could significantly advance our ability to engineer functional cartilage tissue with properties more closely resembling native articular cartilage, potentially transforming treatments for cartilage injuries and degenerative joint diseases .

Product Science Overview

What is Bovine Collagen-II?

Bovine Collagen-II is primarily extracted from the cartilage of cows. This type of collagen is rich in amino acids such as glycine, proline, and hydroxyproline, which are essential for maintaining the structural integrity of cartilage. Unlike other types of collagen, Type II collagen is unique in its ability to support joint health and reduce inflammation.

Extraction and Production

The extraction of Bovine Collagen-II involves several steps:

  1. Collection of Raw Material: Cartilage is collected from cows, typically from their joints.
  2. Processing: The cartilage is cleaned and treated to remove any impurities.
  3. Hydrolysis: The cleaned cartilage is subjected to hydrolysis, a process that breaks down the collagen into smaller peptides, making it easier for the body to absorb.
  4. Purification: The hydrolyzed collagen is then purified to remove any remaining non-collagenous proteins and other contaminants.
  5. Drying and Powdering: The purified collagen is dried and ground into a fine powder, which can be used in various supplements and medical applications.
Benefits and Uses

Bovine Collagen-II has several health benefits, particularly for joint health:

  • Joint Health: It helps in maintaining the integrity of cartilage, reducing joint pain and stiffness, and improving mobility.
  • Anti-inflammatory Properties: It has been shown to reduce inflammation in joints, making it beneficial for conditions like osteoarthritis and rheumatoid arthritis.
  • Skin Health: While not as prominent as Type I collagen, Type II collagen also contributes to skin elasticity and hydration.
Industrial Applications

Bovine Collagen-II is used in various industries:

  • Nutraceuticals: It is a popular ingredient in dietary supplements aimed at improving joint health.
  • Pharmaceuticals: It is used in the formulation of drugs for treating joint disorders.
  • Cosmetics: Some skincare products incorporate Bovine Collagen-II for its potential benefits in improving skin elasticity and hydration.
Research and Development

Ongoing research continues to explore the potential benefits of Bovine Collagen-II. Studies have shown promising results in its ability to support joint health and reduce inflammation. Researchers are also investigating its potential applications in regenerative medicine and tissue engineering.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.